CONVATEC NORWAY AS

Et globalt selskap innen medisinske produkter og teknologier, med en ledende markedsposisjon innen stomipleie, sårbehandling, inkontinens, operasjon, kirurgi og intensiv pleie, og subcutane infusjonsprodukter.

Convatec produkter tilbyr en rekke kliniske og økonomiske fordeler, inkludert forebygging av infeksjon, beskyttelse av utsatt hud, forbedrede behandlingsresultater for pasienter og redusert total kostnad for pleien.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO: ØT
Ørjan Tvenge1974
Chairman of the board: MC
Michael Christian Remy Jensen1967
Years since formation: 17 years; since Jun 12, 2008
Type: Limited company
VAT registered: Yes
Number of employees: 23

Ownership

Number of shares and share classes: 10,001; 1 share class
Total number of shareholders: 1; person

Financials

Total operating income 2023: 84,059,767; NOK
Annual total result 2023: 1,566,499; NOK
Total equity 2023: 25,235,471; NOK

Last update: Sep 24, 2024

Management

Management / administration

Name	Role	Shares
ØT Ørjan Tvenge 1974	Managing Director/CEO	-

Board

Name	Role	Shares
MC Michael Christian Remy Jensen 1967	Chairman	-
ME Mark Edward Warren 1974	Board Member	-
ØT Ørjan Tvenge 1974	Board Member	-

Others

Name	Role	Shares
D DELOITTE AS	Auditor	-
A AZETS INSIGHT AS	Accountant	-
T TMF NORWAY AS	Accountant	-

Last update: Nov 11, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
IC International Services Gmb Convatec	Ordinary shares	10,001	100 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023	2022	2021
Total operating income	84,059,767	100,529,914	85,151,460
Annual Total Result	1,566,499	3,005,561	1,866,895
Total assets	69,762,279	65,734,907	37,984,759
Total liabilities	44,526,807	44,066,281	24,888,849
Total equity	25,235,471	21,668,626	13,095,909

P&L

Year	2023	2022	2021
Total operating income	84,059,767	100,529,914	85,151,460
Total operating costs	82,011,628	96,616,949	82,682,633
Operating result	2,048,139	3,912,965	2,468,827
Financial income/costs	69,253	44,357	3,858
Profit before tax	2,117,392	3,957,322	2,472,685
Total tax & extraordinary income/cost	550,893	951,761	605,790
Annual Total Result	1,566,499	3,005,561	1,866,895

Balance overview

Year	2023	2022	2021
Total fixed assets	301,703	66,299	140,843
Total current assets	69,460,576	65,668,608	37,843,916
Total assets	69,762,279	65,734,907	37,984,759
Short term debt	44,526,807	44,066,281	24,888,849
Long term debt	0	0	0
Total liabilities	44,526,807	44,066,281	24,888,849
Contributed capital	7,383,852	21,668,626	13,095,909
Retained earnings	17,851,619	0	0
Total equity	25,235,471	21,668,626	13,095,909
Total equity and liabilities	69,762,278	65,734,907	37,984,758

CONVATEC NORWAY AS992 780 118